BR112016006129A2 - preparação de 3-fluoropropil-nor-beta-cit radioiodado - Google Patents

preparação de 3-fluoropropil-nor-beta-cit radioiodado

Info

Publication number
BR112016006129A2
BR112016006129A2 BR112016006129A BR112016006129A BR112016006129A2 BR 112016006129 A2 BR112016006129 A2 BR 112016006129A2 BR 112016006129 A BR112016006129 A BR 112016006129A BR 112016006129 A BR112016006129 A BR 112016006129A BR 112016006129 A2 BR112016006129 A2 BR 112016006129A2
Authority
BR
Brazil
Prior art keywords
fluoropropyl
radioiodinated
cit
preparation
beta
Prior art date
Application number
BR112016006129A
Other languages
English (en)
Inventor
C Hudson Edmund
Original Assignee
Mallinckrodt Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Llc filed Critical Mallinckrodt Llc
Publication of BR112016006129A2 publication Critical patent/BR112016006129A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K51/0448Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil tropane or nortropane groups, e.g. ***e

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

a presente invenção refere-se, em linhas gerais, aos processos para a preparação de 3-fluoropropil-nor-ß-cit radioiodado. particularmente, o processo usa um intermediário de arilsilano, evitando, portanto, o uso de hexametildiestanho, e reduzindo o número de etapas necessárias anteriormente para a preparação de 3-fluoropropil-nor-ß-cit radioiodado a partir de éster metilanidroecgonina. a invenção refere-se também à alquilação de um nortropano para o análogo correspondente de n-(3-fluoropropil), utilizando 3-fluoropropanal.
BR112016006129A 2013-09-25 2014-09-25 preparação de 3-fluoropropil-nor-beta-cit radioiodado BR112016006129A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361882039P 2013-09-25 2013-09-25
PCT/US2014/057404 WO2015048250A1 (en) 2013-09-25 2014-09-25 Preparation of radioiodinated 3-fluoropropyl-nor-beta-cit

Publications (1)

Publication Number Publication Date
BR112016006129A2 true BR112016006129A2 (pt) 2017-08-01

Family

ID=52691501

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016006129A BR112016006129A2 (pt) 2013-09-25 2014-09-25 preparação de 3-fluoropropil-nor-beta-cit radioiodado

Country Status (11)

Country Link
US (1) US9339565B2 (pt)
EP (1) EP3049378B1 (pt)
JP (2) JP6224256B2 (pt)
AU (1) AU2014326601B2 (pt)
BR (1) BR112016006129A2 (pt)
CA (1) CA2922723C (pt)
ES (1) ES2711122T3 (pt)
MX (1) MX2016003035A (pt)
PL (1) PL3049378T3 (pt)
TR (1) TR201901758T4 (pt)
WO (1) WO2015048250A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX343345B (es) 2010-05-12 2016-11-01 Nestec Sa Soporte y cápsula para preparar una bebida por centrifugación, sistema y método para preparar una bebida por centrifugación.
US9513907B2 (en) * 2013-08-06 2016-12-06 Intel Corporation Methods, apparatus, instructions and logic to provide vector population count functionality
CA3025145A1 (en) 2015-05-22 2016-12-01 Translational Drug Development Llc Benzamide and active compound compositions and methods of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190601A (en) * 1978-05-31 1980-02-26 Union Carbide Corporation Production of tertiary amines by reductive alkylation
US6123917A (en) * 1990-08-09 2000-09-26 Research Triangle Institute Method for making ***e receptor binding ligands and intermediates therefor
US5698179A (en) * 1992-02-25 1997-12-16 Neuro Imaging Technologies, Llc Iodinated neuroprobe for mapping monoamine reuptake sites
AU5194798A (en) * 1996-10-29 1998-05-22 Guilford Pharmaceuticals Inc. Process for the preparation of radiopharmaceuticals
FI104048B (fi) * 1997-06-16 1999-11-15 Map Medical Technologies Oy Prosessi tuottaa radiojodattuja reseptoriaineita in vivo käyttöön
CA2285516C (en) * 1999-05-12 2010-12-07 President And Fellows Of Harvard College Dopamine transporter imaging agents
JP2001213881A (ja) * 2000-02-02 2001-08-07 Nihon Medi Physics Co Ltd アンヒドロエクゴニン誘導体の合成法
US7309790B2 (en) * 2003-10-03 2007-12-18 Pfizer Inc Chemical compounds
KR100789847B1 (ko) * 2004-12-15 2007-12-28 (주)퓨쳐켐 알코올 용매하에서 유기플루오로 화합물의 제조방법
AU2008324186B2 (en) * 2007-11-07 2014-02-13 Ge Healthcare Bv Stabilization of radiopharmaceuticals
JP5778042B2 (ja) * 2009-02-17 2015-09-16 マリンクロッド エルエルシー ノルモルフィナンの還元的アルキル化のためのプロセス
GB0922023D0 (en) * 2009-12-17 2010-02-03 Ge Healthcare Ltd Preparation of n-monofluoroalkyl compounds

Also Published As

Publication number Publication date
WO2015048250A1 (en) 2015-04-02
JP2016533390A (ja) 2016-10-27
AU2014326601A1 (en) 2016-03-17
JP6224256B2 (ja) 2017-11-01
US20150087838A1 (en) 2015-03-26
TR201901758T4 (tr) 2019-03-21
EP3049378B1 (en) 2018-12-05
EP3049378A1 (en) 2016-08-03
JP2017218460A (ja) 2017-12-14
MX2016003035A (es) 2016-06-10
CA2922723C (en) 2022-04-19
PL3049378T3 (pl) 2019-06-28
AU2014326601B2 (en) 2018-01-18
ES2711122T3 (es) 2019-04-30
CA2922723A1 (en) 2015-04-02
US9339565B2 (en) 2016-05-17
EP3049378A4 (en) 2017-04-19
JP6423936B2 (ja) 2018-11-14

Similar Documents

Publication Publication Date Title
AR118722A2 (es) Proteínas tóxicas para especies de insectos hemípteros
BR112018007017A2 (pt) polipeptídeos
DK3584255T3 (da) Modificerede aminosyrer omfattende en azidogruppe
BR112016002391A2 (pt) composições tópicas e métodos de uso das mesmas
BR112014028203A2 (pt) processo, estrutura secundária e suporte de motor de aeronave
BR112016013492A2 (pt) processo para a preparação de ácidos alcanossulfônicos.
BR112015002091A2 (pt) método para a produção de um polipeptídeo, polipeptídeo, uso de um polipeptídeo e composição
BR112014030071A2 (pt) processo para a fabricação de um vapor de dafd, e, composição
BR112013031493A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto.
CO7200270A2 (es) Azaindolcarboxamidas y azaindoltiocarboxamidas como insecticidas y acaricidas
BR112015018599A2 (pt) Micro-organismos com produtividade de putrescina e processo para produzir putrescina que utiliza os mesmos
BR112015008824A2 (pt) linhagens melhoradas de microalgas e processo das mesmas
BR112017018834A2 (pt) variantes de protoxina-ii e métodos de uso
BR112012030742A2 (pt) ésteres de dialcanolamina quaternários
BR112014005425A2 (pt) processo de sincronização dos motores de um avião
GT201600066A (es) Composiciones y métodos para inhibir la expresión del gen alas1
BR112014026564A2 (pt) formulação, uso de uma formulação, e, processo para a preparação de uma formulação
UY36557A (es) Composición ácida a base de leonardita y aminoácidos
BR112014026565A2 (pt) formulação, uso de uma formulação, e, processo para produzir uma formulação
BR112016007062A2 (pt) variantes de protoxina-ii e métodos de uso
BR112016010223A2 (pt) processo para a preparação de iopamidol.
BR112016030604B8 (pt) Processo para preparação de ácidos 3- hidroxipicolínicos
BR112016006129A2 (pt) preparação de 3-fluoropropil-nor-beta-cit radioiodado
BR112016009727A2 (pt) processo para a preparação de uma mistura de eteramina, e, composição
SMT201700015B (it) Frazione saccaridica da grano, processo per l'isolamento ed uso

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired